Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATLeasesLong-Term Debt RepaymentsMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Shares IssuedShares OutstandingShares RepurchasedShort-Term Debt issuances
Ratios

Cytek Biosciences (CTKB) Other Gross PP&E Adjustments (2020 - 2025)

Historic Other Gross PP&E Adjustments for Cytek Biosciences (CTKB) over the last 6 years, with Q3 2025 value amounting to $16.0 million.

  • Cytek Biosciences' Other Gross PP&E Adjustments rose 254.33% to $16.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $16.0 million, marking a year-over-year increase of 254.33%. This contributed to the annual value of $14.8 million for FY2024, which is 4381.13% up from last year.
  • Per Cytek Biosciences' latest filing, its Other Gross PP&E Adjustments stood at $16.0 million for Q3 2025, which was up 254.33% from $9.7 million recorded in Q2 2025.
  • Over the past 5 years, Cytek Biosciences' Other Gross PP&E Adjustments peaked at $16.0 million during Q3 2025, and registered a low of -$6.0 million during Q1 2022.
  • For the 5-year period, Cytek Biosciences' Other Gross PP&E Adjustments averaged around $7.3 million, with its median value being $8.1 million (2021).
  • Per our database at Business Quant, Cytek Biosciences' Other Gross PP&E Adjustments crashed by 27122.59% in 2022 and then skyrocketed by 64644.93% in 2023.
  • Cytek Biosciences' Other Gross PP&E Adjustments (Quarter) stood at $6.6 million in 2021, then crashed by 79.07% to $1.4 million in 2022, then surged by 646.45% to $10.3 million in 2023, then surged by 43.81% to $14.8 million in 2024, then rose by 8.32% to $16.0 million in 2025.
  • Its Other Gross PP&E Adjustments stands at $16.0 million for Q3 2025, versus $9.7 million for Q2 2025 and $14.7 million for Q1 2025.